Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Giżycko

11 clinical trials in Giżycko, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Giżycko at a glance
11
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Giżycko

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Agencja Badań Medycznych

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Giżycko

What the registry says about research in the country

01 COPD Research

Groundbreaking studies focusing on chronic obstructive pulmonary disease management and treatment optimization. Research includes evaluation of statin therapy for preventive care and assessment of novel triple combination therapies.

  • Exacerbation reduction strategies
  • Lung function improvement
  • Triple therapy effectiveness

Multiple trials exploring innovative approaches to enhance COPD patient outcomes through medication optimization.

02 Severe Asthma Studies

Comprehensive research program investigating severe eosinophilic asthma treatments, with particular focus on the therapeutic potential of dexpramipexole in different patient populations.

  • Exacerbation reduction
  • Long-term safety assessment
  • Pulmonary function evaluation

Extended trials examining both short-term efficacy and long-term safety profiles of emerging treatments.

03 Respiratory Medicine Advances

Innovative clinical research combining pulmonary disease management approaches, including studies of combination therapies and novel therapeutic compounds.

  • Treatment optimization
  • Maintenance therapy evaluation
  • Combined therapeutic approaches

Advanced investigations into respiratory conditions focusing on improving patient quality of life and treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.